Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP382250.RAeTkWqFetiyBFgTpxt7IxRs2cJkCZDlXfizV6eQIquOU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP382250.RAeTkWqFetiyBFgTpxt7IxRs2cJkCZDlXfizV6eQIquOU130_assertion type Assertion NP382250.RAeTkWqFetiyBFgTpxt7IxRs2cJkCZDlXfizV6eQIquOU130_head.
- NP382250.RAeTkWqFetiyBFgTpxt7IxRs2cJkCZDlXfizV6eQIquOU130_assertion description "[However, the unfavorable genotype ERCC2 2251A>C (P = 0.006), tumor invasion depth (P = 0.025), lymph node metastasis (P = 0.011) and cancer stage (P = 0.008) were significantly correlated with early relapse.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP382250.RAeTkWqFetiyBFgTpxt7IxRs2cJkCZDlXfizV6eQIquOU130_provenance.
- NP382250.RAeTkWqFetiyBFgTpxt7IxRs2cJkCZDlXfizV6eQIquOU130_assertion evidence source_evidence_literature NP382250.RAeTkWqFetiyBFgTpxt7IxRs2cJkCZDlXfizV6eQIquOU130_provenance.
- NP382250.RAeTkWqFetiyBFgTpxt7IxRs2cJkCZDlXfizV6eQIquOU130_assertion SIO_000772 18267032 NP382250.RAeTkWqFetiyBFgTpxt7IxRs2cJkCZDlXfizV6eQIquOU130_provenance.
- NP382250.RAeTkWqFetiyBFgTpxt7IxRs2cJkCZDlXfizV6eQIquOU130_assertion wasDerivedFrom befree-20150227 NP382250.RAeTkWqFetiyBFgTpxt7IxRs2cJkCZDlXfizV6eQIquOU130_provenance.
- NP382250.RAeTkWqFetiyBFgTpxt7IxRs2cJkCZDlXfizV6eQIquOU130_assertion wasGeneratedBy ECO_0000203 NP382250.RAeTkWqFetiyBFgTpxt7IxRs2cJkCZDlXfizV6eQIquOU130_provenance.